Donate

Our Policies

Here's where to find each of our privacy policy and terms of service:

Angelman Syndrome News

FAST’s Genetic Services & Education

April 17, 2024 Newsletter | What to Know

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment...

Dr. Cesar Ochoa-Lubinoff

Welcoming FAST Germany

FAST LatAm Updates

Inaugural Angelman Syndrome Congressional Advocacy Day Round-Up

Global Spotlight: Heather Brady

Family Advocates Urge Congress’ Support During Inaugural Angelman Syndrome Congressional Advocacy Day

New FAST-TRAC grant collaboration with Dr. Alvin Huang

How Clinical Trials Work

MENA Angelman Symposium Q&A

A Message from Lauren Black

International Angelman Day 2024 Round-Up

Rare Disease Week 2024

Warrior Wednesday: Kristina

Ultragenyx Pharmaceutical Ultragenyx announces completion of enrollment in Global Phase 1/2 Trial of GT...

2023 Year in Review

New FAST-TRAC Grant

Introducing Ellen Koekoeckx as Global Advisor

FAST’s Genetic Services & Education

April 17, 2024 Newsletter | What to Know

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment...

Dr. Cesar Ochoa-Lubinoff

Welcoming FAST Germany

FAST LatAm Updates

Inaugural Angelman Syndrome Congressional Advocacy Day Round-Up

Global Spotlight: Heather Brady

Family Advocates Urge Congress’ Support During Inaugural Angelman Syndrome Congressional Advocacy Day

New FAST-TRAC grant collaboration with Dr. Alvin Huang

How Clinical Trials Work

MENA Angelman Symposium Q&A

A Message from Lauren Black

International Angelman Day 2024 Round-Up

Rare Disease Week 2024

Warrior Wednesday: Kristina

Ultragenyx Pharmaceutical Ultragenyx announces completion of enrollment in Global Phase 1/2 Trial of GT...

2023 Year in Review

New FAST-TRAC Grant

Introducing Ellen Koekoeckx as Global Advisor